Innovative Treatments in Diabetes Type 1

Bernadette Barbara Lenartowicz and Emilian Snarski

Type 1 diabetes mellitus (T1DM) is a metabolic disease caused by autoimmune destruction of beta cells in the pancreas leading to insufficient production of insulin. The standard..Voir plus»

Clinical Implementation of Novel Kidney Injury Biomarkers for Diagnosis Assessment; the NGAL in a Real-life AKI Setting

Jean-Maxime Côté*, Roxanne Authier, Marie-Claire Bélanger

Acute kidney injury (AKI) is a complex syndrome. Novel kidney injur..Voir plus»

Piebaldism: A Brief Report

Piebaldism is an autosomal dominant congenital pigmentary disorder. It is characterised by white forelock and multiple symmetrical stable depigmented macules. We report a famili..Voir plus»

Blunted Weight Loss at Incident Diabetes is a Strong Marker for Elevated Insulin Resistance in Type 2 Diabetes Mellitus

Navas Nadukkandiyil, Chakrapani Mahabala, Hanadi Al Hamad, Essa Al Sulaiti, Marwan Badri Ramadan and Noorudeen Kaladi kunnummal

Aim: To find out the relation between insulin resistance and weight status along with other clinical markers in individuals who are newly detected with type 2Voir plus»

Mucoperosteum of the Palate – An Ideal and Versatile Reconstructive Tool

Dr. Manjunath KN* and Dr. Veena P Waiker

Background: Palate is a complex structure separating oropharynx and nasopharynx. However reconstruction of the defects of palate is much simpler because of the available versati..Voir plus»

Cost Variation Analysis of Oral Anti-Diabetic Drugs Currently Available in the Indian Pharmaceutical Market.

Khadga Raj Aran

Diabetes Mellitus (DM) is a chronic condition that affects millions of people throughout the globe and are expected to take medicines for a longer time and even medicines for a ..Voir plus»